Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists*

Miguel Unda-Urzáiz, Jose María Alonso-Herreros, Jesus Maria Fernández-Gómez, Marisa Gaspar-Carreño, Jose Manuel Cozar-Olmos, Ana Cristina Cercós Lleti, en representación de Trabajo de Medicamentos Peligrosos de Trabajo de Medicamentos Peligrosos de la Sociedad Española de Farmacia del Grupo de Hospitalaria

The intravesical administration of hazardous drug products is a  standard practice in the urology setting, which potentially exposing medical  personnel to these drug products. It was deemed necessary to have a consensus document among the scientific societies involved (the Spanish Urological  Association and the Spanish Society of Hospital Pharmacy) that collects the best  available evidence on the safest handling possible of dangerous drug products in the setting of urology departments. We reviewed the legislation and recommendations on the handling of  dangerous drug products, both at the national and international level. There is national legislation and regulations for protecting workers who  handle dangerous drugs and products, as well as  recommendations for handling to protect both the product and workers. Following the strategic lines of the European Parliament for 2014- 2020 in the chapter on occupational safety and health, the Spanish Urological  Association and the Spanish Society of Hospital Pharmacy proposed a series of  actions that decrease the risks of exposure for practitioners and caregivers  involved in the handling of these products. After this review, 19 recommendations were established for  handling dangerous drug products, which can be summarised as the need to  train all individuals involved (from management teams to patients and  caregivers), adopt systems that prevent contaminating leaks, implement  exposure surveillance programmes and optimise available resources.